Articles, announcements and insights from Horizon Discovery

Patient derived xenograft (PDX) use in cancer research

Apr 18, 2018 11:59:19 AM No Comments


Due to obvious ethical considerations, cancer research conducted in humans is restricted to observational and analytical studies, with therapy focused clinical trials being the one exception to this rule. Preclinical mouse tumour models therefore provide a critical intermediate experimental model system tying together more basic in vitro research with studies in humans, thereby providing bench-to-bedside translational oncology research.

Read More PDX, in vivo, Patient Derived Xenografts, Oncology, Immunodeficient Mice

Subscribe to Email Updates